World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
30369
World Ranking
8359
National Ranking
4319

Overview

Artur V. Cideciyan is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on retinal development and disorders, with a significant body of work related to retinal diseases and treatments. The scientist's scholarly output spans the fields of medicine and biochemistry, genetics, and molecular biology, with publications also covering ophthalmology, molecular biology, cellular and molecular neuroscience, radiology, nuclear medicine and imaging, and genetics.

The main topics addressed in their research include:

  • Retinal Development and Disorders
  • Retinal Diseases and Treatments
  • Photoreceptor and Optogenetics Research
  • Glaucoma and Retinal Disorders
  • Ocular Disorders and Treatments
  • Retinal and Macular Surgery
  • Ophthalmology and Visual Impairment Studies

Among the frequently published venues where Artur V. Cideciyan's work appears are:

  • Translational Vision Science & Technology
  • American Journal of Ophthalmology
  • Investigative Ophthalmology & Visual Science
  • Vision Research
  • iScience

Frequent collaborators include:

  • Samuel G. Jacobson
  • Alexander Sumaroka
  • Alejandro J. Román
  • Małgorzata Świder
  • Alexandra V. Garafalo

Selected recent papers by Artur V. Cideciyan include:

  • Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report (2021, Nature Medicine)
  • Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial (2022, Nature Medicine)
  • Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium (2020, Translational Vision Science & Technology)
  • Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease (2021, Progress in Retinal and Eye Research)
  • Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations (2021, iScience)

Best Publications

  • Gene therapy restores vision in a canine model of childhood blindness.

    Gregory M. Acland;Gustavo D. Aguirre;Jharna Ray;Qi Zhang

  • Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

    William W. Hauswirth;Tomas S. Aleman;Shalesh Kaushal;Artur V. Cideciyan

  • Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

    Artur V. Cideciyan;Tomas S. Aleman;Sanford L. Boye;Sharon B. Schwartz

  • Interim Results from the International Trial of Second Sight's Visual Prosthesis

    Mark S. Humayun;Jessy D. Dorn;Lyndon Da Cruz;Gislin Dagnelie

  • Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years

    Samuel G. Jacobson;Artur V. Cideciyan;Ramakrishna Ratnakaram;Elise Heon

  • Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood Blindness

    Gregory M. Acland;Gustavo D. Aguirre;Jean Bennett;Tomas S. Aleman

  • Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate

    Neena B. Haider;Samuel G. Jacobson;Artur V. Cideciyan;Ruth Swiderski

  • Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

    Artur V. Cideciyan;Samuel G. Jacobson;William A. Beltran;Alexander Sumaroka

  • Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year

    Artur V. Cideciyan;William W. Hauswirth;Tomas S. Aleman;Shalesh Kaushal

  • Improvement and decline in vision with gene therapy in childhood blindness.

    Samuel G. Jacobson;Artur V. Cideciyan;Alejandro J. Roman;Alexander Sumaroka

  • Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Lyndon da Cruz;Jessy D. Dorn;Mark S. Humayun;Gislin Dagnelie

  • Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa

    Petters Rm;Alexander Ca;Wells Kd;Collins Eb

  • Psychophysical Evidence for Rod Vulnerability in Age-Related Macular Degeneration

    Cynthia Owsley;Gregory R. Jackson;Artur V. Cideciyan;Yijun Huang

  • Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa

    William A. Beltran;Artur V. Cideciyan;Alfred S. Lewin;Simone Iwabe

  • Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.

    Artur V. Cideciyan

  • Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man

    Artur V. Cideciyan;Donald C. Hood;Yijun Huang;Eyal Banin

  • Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina

    Jean Bennett;Albert M. Maguire;Artur V. Cideciyan;Michael Schnell

  • Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.

    J. Preston Van Hooser;Tomas S. Aleman;Yu Guang He;Artur V. Cideciyan

  • Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success

    Samuel G. Jacobson;Tomas S. Aleman;Artur V. Cideciyan;Alexander Sumaroka

  • Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence

    Artur V. Cideciyan;Tomas S. Aleman;Malgorzata Swider;Sharon B. Schwartz

Frequent Co-Authors

Samuel G. Jacobson
Samuel G. Jacobson University of Pennsylvania
Tomas S. Aleman
Tomas S. Aleman University of Pennsylvania
Edwin M. Stone
Edwin M. Stone University of Iowa
Gustavo D. Aguirre
Gustavo D. Aguirre University of Pennsylvania
William W. Hauswirth
William W. Hauswirth University of Florida
Sanford L. Boye
Sanford L. Boye University of Florida
Elise Héon
Elise Héon University of Toronto
Anand Swaroop
Anand Swaroop National Institutes of Health
Jean Bennett
Jean Bennett University of Pennsylvania
David G. Birch
David G. Birch The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up various pathways beyond becoming a physician. Today, online degree programs provide flexible and affordable options to help you advance in the healthcare field or pivot to related specialties.

For those interested in healthcare leadership, the most affordable online MHA programs offer a strong foundation in management and administration. If your goal is to practice medicine at the highest clinical level, consider exploring the least expensive DNP programs.

If pharmacy interests you, pharmacy school online options make it possible to earn a doctorate while balancing work and personal commitments. Additionally, technology-driven roles are booming, and a health information management bachelor degree online prepares you to manage healthcare data and inform decision-making processes.

No matter your interests, these flexible online degrees can enhance your skill set, improve your career prospects, and help meet the growing needs of the healthcare industry.

Best Scientists Citing Artur V. Cideciyan

Trending Scientists